ProShare Advisors’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $520K | Buy |
20,921
+368
| +2% | +$9.53K | ﹤0.01% | 1040 |
|
|
2025
Q4 | $522K | Buy |
20,553
+2,660
| +15% | +$59.3K | ﹤0.01% | 1113 |
|
|
2025
Q3 | $288K | Sell |
17,893
-2,500
| -12% | -$40.5K | ﹤0.01% | 1455 |
|
|
2025
Q2 | $326K | Buy |
20,393
+165
| +0.8% | +$2.5K | ﹤0.01% | 1385 |
|
|
2025
Q1 | $346K | Sell |
20,228
-3,072
| -13% | -$64.3K | ﹤0.01% | 1319 |
|
|
2024
Q4 | $577K | Buy |
23,300
+3,681
| +19% | +$104K | ﹤0.01% | 1186 |
|
|
2024
Q3 | $559K | Buy |
19,619
+3,375
| +21% | +$99.5K | ﹤0.01% | 1075 |
|
|
2024
Q2 | $429K | Sell |
16,244
-3,633
| -18% | -$103K | ﹤0.01% | 1059 |
|
|
2024
Q1 | $642K | Buy |
19,877
+1,703
| +9% | +$62.1K | ﹤0.01% | 953 |
|
|
2023
Q4 | $766K | Buy |
18,174
+2,620
| +17% | +$96.4K | ﹤0.01% | 830 |
|
|
2023
Q3 | $597K | Buy |
15,554
+99
| +0.6% | +$2.24K | ﹤0.01% | 851 |
|
|
2023
Q2 | $293K | Buy |
15,455
+1,193
| +8% | +$22.2K | ﹤0.01% | 1287 |
|
|
2023
Q1 | $221K | Sell |
14,262
-2,147
| -13% | -$37.3K | ﹤0.01% | 1392 |
|
|
2022
Q4 | $291K | Buy |
16,409
+2,186
| +15% | +$27.5K | ﹤0.01% | 1252 |
|
|
2022
Q3 | $80K | Buy |
14,223
+659
| +5% | +$3.22K | ﹤0.01% | 1600 |
|
|
2022
Q2 | $53K | Sell |
13,564
-6,090
| -31% | -$26.3K | ﹤0.01% | 1696 |
|
|
2022
Q1 | $108K | Sell |
19,654
-5,301
| -21% | -$33K | ﹤0.01% | 2012 |
|
|
2021
Q4 | $212K | Sell |
24,955
-4,746
| -16% | -$39.2K | ﹤0.01% | 1991 |
|
|
2021
Q3 | $258K | Buy |
29,701
+2,366
| +9% | +$21.3K | ﹤0.01% | 1653 |
|
|
2021
Q2 | $289K | Buy |
27,335
+3,758
| +16% | +$52.5K | ﹤0.01% | 1921 |
|
|
2021
Q1 | $378K | Buy |
23,577
+162
| +0.7% | +$4.27K | ﹤0.01% | 1652 |
|
|
2020
Q4 | $1.08M | Buy |
+23,415
| New | +$1.08M | ﹤0.01% | 843 |
|
Other funds holding IMVT
DTC
BBA
TCM
VPM
VCM
